Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in active psoriatic arthritis
ISRCTN76859006Phase 3Completed
- Sponsor
- Medical University of Vienna
- Start
- Sep 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in psoriatic arthritis (PsA) comparing Rituximab + methotrexate with Placebo + methotrexate (2 arms). Primary endpoint: Psoriatic Arthritis Response Criteria. Started Sep 2006; status: completed.
02
Drugs
rituximab
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on ISRCTN76859006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN76859006.